Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell Tumour

Retroperitoneal space
DOI: 10.1016/j.euf.2024.06.011 Publication Date: 2024-08-01T12:09:21Z
ABSTRACT
Treatment de-escalation strategies in patients with seminoma with retroperitoneal metastases are being investigated in ongoing clinical trials. Primary retroperitoneal lymph node dissection conducted by expert surgeons may avoid any cytotoxic treatment and related long-term side effects in ≥70% of patients with clinical stage IIA/B seminoma.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (16)
CITATIONS (1)